Patents Assigned to Bayer Schering Pharma AG
  • Publication number: 20150005488
    Abstract: The present invention relates to a process for the preparation of 17?-(3-hydroxypropyl)-17?-hydroxysteroids of the formula I starting from 17-ketosteroids of the formula III via the intermediates of the formula V wherein the radicals R3, R5, R6, R7, R10, R13, R15, R16, R40, R41 and R42 have the meaning indicated in the description.
    Type: Application
    Filed: September 16, 2014
    Publication date: January 1, 2015
    Applicant: Bayer Schering Pharma AG
    Inventors: Claus Christian Haeselhoff, Mike Petersen
  • Patent number: 8680117
    Abstract: The present invention relates to compounds of formula I, processes for their production and their use as anti-inflammatory agents.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: March 25, 2014
    Assignee: Bayer Schering Pharma AG
    Inventors: Markus Berger, Hartmut Rehwinkel, Thomas Zollner, Bkkehard May, Jorma Hassfeld, Heike Schacke
  • Patent number: 8491906
    Abstract: The present invention relates to selectively targeting tumoral vasculature in vivo using a human recombinant scFv, L19, to the angiogenesis marker ED-B domain of fibronectin. In preferred embodiments, a complete human IgG1 is employed having the variable regions of L19. In other preferred embodiments is employed a mini-immunoglobulin generated by fusing the scFv L19 to the constant CH4 domain of a secretory IgE isoform that naturally contains a cysteine in its COOH terminal and which forms a covalently linked dimer. Different in vivo behavior of the antibody formats is exploitable for different diagnostic and/or therapeutic purposes, depending on clinical needs and disease. The antibody molecules may be labelled as described.
    Type: Grant
    Filed: March 11, 2003
    Date of Patent: July 23, 2013
    Assignees: Philogen S.p.A., Bayer Schering Pharma AG
    Inventors: Laura Borsi, Barbara Carnemolla, Enrica Balza, Patrizia Castellani, Luciano Zardi, Matthias Friebe, Christoph-Stephan Hilger
  • Publication number: 20130060039
    Abstract: The invention relates to novel benzothiophene-, benzofuran-, and indole ureas and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning, and/or memory.
    Type: Application
    Filed: April 6, 2012
    Publication date: March 7, 2013
    Applicant: Bayer Schering Pharma AG
    Inventors: Timo Flessner, Frank-Gerhard Böss, Christina Erb, Frank-Thorsten Hafner, Katrin Schnizler, Dieter Lang, Joachim Luithle, Marja Van Kampen, Franz-Josef van der Staay
  • Publication number: 20120258964
    Abstract: The invention relates to novel 2-heteroaryl carboxamides and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: March 6, 2012
    Publication date: October 11, 2012
    Applicant: Bayer Schering Pharma AG
    Inventors: Joachim Luithle, Frank-Gerhard Böss, Christina Erb, Frank-Thorsten Hafner, Katrin Schnizler, Timo Flessner, Marja Van Kampen, Franz-Josef Van Der Staay
  • Patent number: 8263040
    Abstract: The invention relates to the subjects characterized in the patent claims, namely metal chelates having a perfluorinated PEG radical, processes for their preparation, and their use, processes for their preparation and their use in NMR and X-ray diagnosis, radiodiagnosis and radiotherapy, and in MRT lymphography.
    Type: Grant
    Filed: October 17, 2007
    Date of Patent: September 11, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Johannes Platzek, Heiko Schirmer, Hanns-Joachim Weinmann, Bernd Misselwitz, Ludwig Zorn
  • Publication number: 20120202842
    Abstract: The invention relates to novel 2-heteroarylcarboxamides, processes for their preparation, and their use for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.
    Type: Application
    Filed: November 4, 2011
    Publication date: August 9, 2012
    Applicant: Bayer Schering Pharma AG
    Inventors: Martin Hendrix, Frank-Gerhard Böß, Christina Erb, Timo Fleßner, Marja van Kampen, Joachim Luithle, Christoph Methfessel, Welf-Burkhard Wiese
  • Patent number: 8211930
    Abstract: A compound of formula Ia: The present invention relates to novel indazolyl derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments
    Type: Grant
    Filed: May 19, 2009
    Date of Patent: July 3, 2012
    Assignees: AstraZeneca AB, Bayer Schering Pharma AG
    Inventors: Markus Berger, Hartmut Rehwinkel, Jan Dahmén, Anders Eriksson, Thomas Hansson, Nafizal Hossain, Per Tomas Klingstedt, Matti Lepistö, Stinabritt Nilsson, Martin Hemmerling, Karl Edman
  • Patent number: 8187632
    Abstract: The present invention relates to an orally administrable preparation comprising a quinolone antibiotic which releases the active compound with a delay.
    Type: Grant
    Filed: June 14, 2007
    Date of Patent: May 29, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Venkata-Rangarao Kanikanti, Roland Rupp, Wolfgang Weber, Peter Deuringer, Jan-Olav Henck, Heino Stab, Takaaki Nishioka, Yoshifumi Katakawa, Chika Taniguchi, Hitoshi Ichihashi
  • Patent number: D657126
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: April 10, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Sabine Leifeld, Heike Ranze, Parviz Bazargani, Michael Wiklund
  • Patent number: D657128
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: April 10, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Sabine Leifeld, Heike Ranze, Parviz Bazargani, Michael Wiklund
  • Patent number: D657129
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: April 10, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Sabine Leifeld, Heike Ranze, Parviz Bazargani, Michael Wiklund
  • Patent number: D657130
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: April 10, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Sabine Leifeld, Heike Ranze, Parviz Bazargani, Michael Wiklund
  • Patent number: D657131
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: April 10, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Sabine Leifeld, Heike Ranze, Parviz Bazargani, Michael Wiklund
  • Patent number: D657548
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: April 17, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Sabine Leifeld, Heike Ranze, Parviz Bazargani, Michael Wiklund
  • Patent number: D657549
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: April 17, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Sabine Leifeld, Heike Ranze, Parviz Bazargani, Michael Wiklund
  • Patent number: D657550
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: April 17, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Sabine Leifeld, Heike Ranze, Parviz Bazargani, Michael Wiklund
  • Patent number: D665161
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: August 14, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Sabine Leifeld, Heike Ranze, Parviz Bazargani, Michael Wiklund
  • Patent number: D665162
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: August 14, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Sabine Leifeld, Heike Ranze, Parviz Bazargani, Michael Wiklund
  • Patent number: D665163
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: August 14, 2012
    Assignee: Bayer Schering Pharma AG
    Inventors: Sabine Leifeld, Heike Ranze, Parviz Bazargani, Michael Wiklund